Partnership Announcements| September 2019
Going Long with Verafin
Over the course of Spectrum’s 25 year history, we occasionally have the opportunity to forge especially long-term partnerships with companies that extend beyond typical private equity investment timelines.
While each of these investments – Ancestry, Definitive Healthcare, SurveyMonkey, Trintech and The Knot Worldwide among others in our portfolio – has usually required some creativity and flexibility to extend our investment hold period, it has always been in the context of deeply-rooted conviction in a category defining company and team, and a really compelling growth opportunity.
We are thrilled to add Verafin to the list of companies where we have leaned in to ‘going long’ alongside the management team.
CEO Jamie King and the rest of the Verafin team have built a very special business that we’ll expand on in the coming weeks in a more fulsome blog post, but for now we wanted to express our gratitude to the team for all that they have accomplished to date, and relay our enthusiasm for what we believe is going to be a very exciting next chapter.
Content contained in this blog post is not intended to and does not constitute investment advice. Your use of the information in this blog post and materials linked is at your own risk. Spectrum Equity does not make any guarantee or other promise as to any results that may be obtained from using this content. No one should make any investment decision without first consulting his or her own financial advisor and conducting his or her own research and due diligence. Past performance is not indicative of future results, and there is a possibility of loss in connection with an investment in any Spectrum Fund. To the maximum extent permitted by law, Spectrum Equity disclaims any and all liability in the event any information, commentary, analysis, and/or opinions prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses. The specific companies identified above does not represent all of Spectrum’s investments, and no assumptions should be made that any investments identified were or will be profitable.